Association of the endothelial nitric oxide synthase (eNOS) 4a/b polymorphism with the risk of incident diabetic retinopathy in patients with type 2 diabetes mellitus: a systematic review and updated meta-analysis

References

• Bhatwadekar AD, Shughoury A, Belamkar A, et al. Genetics of diabetic retinopathy, a leading cause of irreversible blindness in the industrialized world. Genes. 2021;12(8):1. doi: 10.3390/genes12081200.
   Web of Science ®Google Scholar
• Sivaprasad S, Gupta B, Crosby-Nwaobi R, et al. Prevalence of diabetic retinopathy in various ethnic groups: a worldwide perspective. Surv Ophthalmol. 2012;57(4):347–14. doi: 10.1016/j.survophthal.2012.01.004.
   PubMed Web of Science ®Google Scholar
• Teo ZL, Tham YC, Yu M, et al. Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis. Ophthalmology. 2021;128(11):1580–1591. doi: 10.1016/j.ophtha.2021.04.027.
   PubMed Web of Science ®Google Scholar
• Suganthalakshmi B, Anand R, Kim R, et al. Association of VEGF and eNOS gene polymorphisms in type 2 diabetic retinopathy. Mol Vis. 2006;12:336–341.
   PubMed Web of Science ®Google Scholar
• Gui F, You Z, Fu S, et al. Endothelial dysfunction in diabetic retinopathy. Front Endocrinol. 2020;11:591. doi: 10.3389/fendo.2020.00591.
   PubMed Web of Science ®Google Scholar
• Yang J, Liu Z. Mechanistic pathogenesis of endothelial dysfunction in diabetic nephropathy and retinopathy. Front Endocrinol. 2022;13:816400. doi: 10.3389/fendo.2022.816400.
   PubMed Web of Science ®Google Scholar
• Siasos G, Gouliopoulos N, Moschos MM, et al. Role of endothelial dysfunction and arterial stiffness in the development of diabetic retinopathy. Diabetes Care. 2015;38(1):e9–e10. doi: 10.2337/dc14-1741.
   PubMed Web of Science ®Google Scholar
• Mehrab-Mohseni M, Tabatabaei-Malazy O, Hasani-Ranjbar S, et al. Endothelial nitric oxide synthase VNTR (intron 4 a/b) polymorphism association with type 2 diabetes and its chronic complications. Diabetes Res Clin Pract. 2011;91(3):348–352. doi: 10.1016/j.diabres.2010.12.030.
   PubMed Web of Science ®Google Scholar
• Khaloo P, Qahremani R, Rabizadeh S, et al. Nitric oxide and TNF-α are correlates of diabetic retinopathy independent of hs-CRP and HbA1c. Endocrine. 2020;69(3):536–541. doi: 10.1007/s12020-020-02353-x.
   PubMed Web of Science ®Google Scholar
• Singh CB, Singh K, Rajni S, et al. Endothelial nitric oxide synthase gene polymorphism and type 2 diabetic retinopathy among Asian Indians. Acta Diabetol. 2012;49(6):481–488. doi:10.1007/s00592-012-0437-7.
   PubMed Web of Science ®Google Scholar
• She C, Yang X, Gu H, et al. The association of variable number of tandem repeats polymorphism in the endothelial nitric oxide synthase gene and diabetic retinopathy. Zhonghua Yan Ke Za Zhi. 2015;51:338–343.
   PubMedGoogle Scholar
• Shi X, Li P, Liu H, et al. Oxidative stress, vascular endothelium, and the pathology of neurodegeneration in retina. Antioxidants. 2022;11(3):543. doi: 10.3390/antiox11030543.
   Web of Science ®Google Scholar
• Ruan Y, Jiang S, Musayeva A, et al. Oxidative stress and vascular dysfunction in the retina: therapeutic strategies. Antioxidants. 2020;9(8):761. doi: 10.3390/antiox9080761.
   Web of Science ®Google Scholar
• Erdinest N, London N, Ovadia H, et al. Nitric oxide interaction with the eye. Vision. 2021;5(2):29. doi: 10.3390/vision5020029.
   Google Scholar
• Bregar D, Cilenšek I, Mankoč S, et al. The joint effect of the endothelin receptor B gene (EDNRB) polymorphism rs10507875 and nitric oxide synthase 3 gene (NOS3) polymorphism rs869109213 in Slovenian patients with type 2 diabetes mellitus and diabetic retinopathy. Bosn J Basic Med Sci. 2018;18(1):80–86. doi: 10.17305/bjbms.2017.2244.
   PubMed Web of Science ®Google Scholar
• Narne P, Ponnaluri KC, Siraj M, et al. Association analysis of polymorphisms in genes related to oxidative stress in South Indian type 2 diabetic patients with retinopathy. Ophthalmic Genet. 2016;37(1):1–8. doi: 10.3109/13816810.2014.895015.
   PubMed Web of Science ®Google Scholar
• Izumi N, Nagaoka T, Mori F, et al. Relation between plasma nitric oxide levels and diabetic retinopathy. Jpn J Ophthalmol. 2006;50(5):465–468. doi: 10.1007/s10384-006-0344-y.
   PubMed Web of Science ®Google Scholar
• Chen Y, Huang H, Zhou J, et al. Polymorphism of the endothelial nitric oxide synthase gene is associated with diabetic retinopathy in a cohort of West Africans. Mol Vis. 2007;13:2142–2147.
   PubMed Web of Science ®Google Scholar
• Uthra S, Raman R, Mukesh BN, et al. Intron 4 VNTR of endothelial nitric oxide synthase (eNOS) gene and diabetic retinopathy in type 2 patients in Southern India. Ophthalmic Genet. 2007;28(2):77–81. doi: 10.1080/13816810701209669.
   PubMed Web of Science ®Google Scholar
• Cosentino F, Hishikawa K, Katusic ZS, et al. High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation. 1997;96(1):25–28. doi: 10.1161/01.cir.96.1.25.
   PubMed Web of Science ®Google Scholar
• Sharma A, Valle ML, Beveridge C, et al. Unraveling the role of genetics in the pathogenesis of diabetic retinopathy. Eye. 2019;33(4):534–541. doi: 10.1038/s41433-019-0337-y.
   PubMed Web of Science ®Google Scholar
• de Syllos RW, Sandrim VC, Lisboa HR, et al. Endothelial nitric oxide synthase genotype and haplotype are not associated with diabetic retinopathy in diabetes type 2 patients. Nitric Oxide. 2006;15(4):417–422. doi: 10.1016/j.niox.2006.02.002.
   PubMed Web of Science ®Google Scholar
• Li M, Li X, Zhao M, et al. Association of genetic polymorphism of nitric oxide synthase and diabetic retinopathy. Chin J Ocul Fundus Dis. 2010;26:135–138.
   Google Scholar
• Midani F, Ben Amor Z, El Afrit MA, et al. The role of genetic variants (rs869109213 and rs2070744) of the eNOS gene and BglII in the α(2) subunit of the α(2)β(1) integrin gene in diabetic retinopathy in a Tunisian population. Semin Ophthalmol. 2019;34(5):365–374. doi: 10.1080/08820538.2019.1632354.
   PubMed Web of Science ®Google Scholar
• Marsden PA, Heng HH, Scherer SW, et al. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem. 1993;268(23):17478–17488.
   PubMed Web of Science ®Google Scholar
• Nadaud S, Bonnardeaux A, Lathrop M, et al. Gene structure, polymorphism and mapping of the human endothelial nitric oxide synthase gene. Biochem Biophys Res Commun. 1994;198(3):1027–1033. doi: 10.1006/bbrc.1994.1146.
   PubMed Web of Science ®Google Scholar
• Tsukada T, Yokoyama K, Arai T, et al. Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem Biophys Res Commun. 1998;245(1):190–193. doi: 10.1006/bbrc.1998.8267.
   PubMed Web of Science ®Google Scholar
• Awata T, Neda T, Iizuka H, et al. Endothelial nitric oxide synthase gene is associated with diabetic macular edema in type 2 diabetes. Diabetes Care. 2004;27(9):2184–2190. doi: 10.2337/diacare.27.9.2184.
   PubMed Web of Science ®Google Scholar
• Yu Q-Q, Yao Y, Zhu J, et al. Association between a 27-bp variable number of tandem repeat polymorphism in intron 4 of the eNOS gene and risk for diabetic retinopathy type 2 diabetes mellitus: a meta-analysis. Curr Eye Res. 2014;39(10):1052–1058. doi: 10.3109/02713683.2014.894078.
   PubMed Web of Science ®Google Scholar
• Dong J, Ping Y, Wang Y, et al. The roles of endothelial nitric oxide synthase gene polymorphisms in diabetes mellitus and its associated vascular complications: a systematic review and meta-analysis. Endocrine. 2018;62(2):412–422. doi: 10.1007/s12020-018-1683-4.
   PubMed Web of Science ®Google Scholar
• Ma ZJ, Chen R, Ren HZ, et al. Association between eNOS 4b/a polymorphism and the risk of diabetic retinopathy in type 2 diabetes mellitus: a meta-analysis. J Diabetes Res. 2014;2014:549747.
   PubMed Web of Science ®Google Scholar
• Zhao S, Li T, Zheng B, et al. Nitric oxide synthase 3 (NOS3) 4b/a, T-786C and G894T polymorphisms in association with diabetic retinopathy susceptibility: a meta-analysis. Ophthalmic Genet. 2012;33(4):200–207. doi: 10.3109/13816810.2012.675398.
   PubMed Web of Science ®Google Scholar
• Di Pietro M, Filardo S, Simonelli I, et al. Cervicovaginal microbiota composition in Chlamydia trachomatis infection: a systematic review and meta-analysis. IJMS. 2022;23(17):9554. doi: 10.3390/ijms23179554.
   Google Scholar
• Stang A. Critical evaluation of the Newcastle-Ottawa Scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–605. doi: 10.1007/s10654-010-9491-z.
   PubMed Web of Science ®Google Scholar
• McPheeters ML, Kripalani S, Peterson NB, et al. Closing the quality gap: revisiting the state of the science (vol. 3: quality improvement interventions to address health disparities). Evid Rep Technol Assess. 2012;208(3):1–475.
   PubMedGoogle Scholar
• Ines C, Sara M, Mojca GP, et al. The 4a/4a genotype of the VNTR polymorphism for endothelial nitric oxide synthase (eNOS) gene predicts risk for proliferative diabetic retinopathy in Slovenian patients (Caucasians) with type 2 diabetes mellitus. Mol Biol Rep. 2012;39(6):7061–7067. doi: 10.1007/s11033-012-1537-8.
   PubMed Web of Science ®Google Scholar
• Santos KG, Crispim D, Canani LH, et al. Relationship of endothelial nitric oxide synthase (eNOS) gene polymorphisms with diabetic retinopathy in Caucasians with type 2 diabetes. Ophthalmic Genet. 2012;33(1):23–27. doi: 10.3109/13816810.2011.620057.
   PubMed Web of Science ®Google Scholar
• Ezzidi I, Mtiraoui N, Mohamed MB, et al. Endothelial nitric oxide synthase Glu298Asp, 4b/a, and T-786C polymorphisms in type 2 diabetic retinopathy. Clin Endocrinol. 2008;68(4):542–546. doi: 10.1111/j.1365-2265.2007.03089.x.
   PubMed Web of Science ®Google Scholar
• Petrovic MG, Cilensek I, Petrovic D. Manganese superoxide dismutase gene polymorphism (V16A) is associated with diabetic retinopathy in Slovene (Caucasians) type 2 diabetes patients. Dis Markers. 2008;24(1):59–64. doi: 10.1155/2008/940703.
   PubMed Web of Science ®Google Scholar
• Yue M, Yu X, Dai H, et al. Diabetic retinopathy and variable number tandem repeat polymorphism in intron 4 of endothelial nitric oxide synthase gene. Chin J Ocul Fundus Dis. 2011;27:214–217.
   Google Scholar
• Zhang M, Liu H, Xu Y, et al. Endothelial nitric oxide synthase gene intron 4 polynlorphism is associated with type 2 diabetic rentinopathy. Chin J Endocrinol Metab. 2005;21:146–147.
   Google Scholar
• Sun H, Yang M, Liu S, et al. Association of endothelial nitric oxide synthase gene polymorphisms with type 2 diabetes meatus and diabetic retinopathy. Chin J Endocrinol Metab. 2004;20:52–53.
   Google Scholar
• Bastola P, Khatiwada S, Khadka M, et al. Diabetic retinopathy among diabetic patients at a tertiary care hospital: a descriptive cross-sectional study. JNMA J Nepal Med Assoc. 2022;60(247):234–240. doi: 10.31729/jnma.7243.
   PubMed Web of Science ®Google Scholar
• Levy RM, Prince JM, Billiar TR. Nitric oxide: a clinical primer. Crit Care Med. 2005;33(12 Suppl):S492–S495. doi: 10.1097/01.ccm.0000191726.33105.f2.
   PubMed Web of Science ®Google Scholar
• Jing W, Bo D, Aijun S. Effect of endothelial-type nitric oxide synthase gene polymorphisms on nitric oxide levels. Med Recapitulate. 2014;20:580–583.
   Google Scholar
• Blum A, Meerson A, Rohana H, et al. MicroRNA-423 may regulate diabetic vasculopathy. Clin Exp Med. 2019;19(4):469–477. doi: 10.1007/s10238-019-00573-8.
   PubMed Web of Science ®Google Scholar
• Gericke A, Wolff I, Musayeva A, et al. Retinal arteriole reactivity in mice lacking the endothelial nitric oxide synthase (eNOS) gene. Exp Eye Res. 2019;181:150–156. doi: 10.1016/j.exer.2019.01.022.
   PubMed Web of Science ®Google Scholar
• Nakagawa T, Johnson RJ. Endothelial nitric oxide synthase. Contrib Nephrol. 2011;170:93–101. doi: 10.1159/000324954.
   PubMed Web of Science ®Google Scholar
• Hoang HH, Padgham SV, Meininger CJ. L-arginine, tetrahydrobiopterin, nitric oxide and diabetes. Curr Opin Clin Nutr Metab Care. 2013;16(1):76–82. doi: 10.1097/MCO.0b013e32835ad1ef.
   PubMed Web of Science ®Google Scholar
• Lee YH, Bae SC, Choi SJ, et al. Association between the CTLA-4 + 49 a/G polymorphism and susceptibility to rheumatoid arthritis: a meta-analysis. Mol Biol Rep. 2012;39(5):5599–5605. doi: 10.1007/s11033-011-1364-3.
   PubMed Web of Science ®Google Scholar
• Lee YH, Song GG. Associations between eNOS polymorphisms and susceptibility to Behcet’s disease: a meta-analysis. J Eur Acad Dermatol Venereol. 2012;26(10):1266–1271. doi: 10.1111/j.1468-3083.2011.04280.x.
   PubMed Web of Science ®Google Scholar
• Ramos RB, Fabris VC, Brondani Lde A, et al. Association between rs7903146 and rs12255372 polymorphisms of transcription factor 7-like 2 gene and polycystic ovary syndrome: a systematic review and meta-analysis. Endocrine. 2015;49(3):635–642. doi: 10.1007/s12020-015-0541-x.
   PubMed Web of Science ®Google Scholar
• Kuodi P, Patterson J, Silal S, et al. Characterisation of the environmental presence of hepatitis a virus in low-income and Middle-income countries: a systematic review and meta-analysis. BMJ Open. 2020;10(9):e036407. doi: 10.1136/bmjopen-2019-036407.
   PubMed Web of Science ®Google Scholar
• Chen YY, Feng YY, Chen YN, et al. Association between ABCB1 C3435T polymorphism and antiepileptic drug resistance in epilepsy: an updated meta-analysis based on 62 studies. Int J Clin Pharmacol Ther. 2022;60(3):146–158. doi: 10.5414/CP204045.
   PubMed Web of Science ®Google Scholar